Brain amyloid and Alzheimer disease.

Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab (2012) 1.62

Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol (1992) 1.39

Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol (1990) 1.08

Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am J Pathol (1990) 1.06

Immunohistochemical study of cerebral amyloid angiopathy. II. Enhancement of immunostaining using formic acid pretreatment of tissue sections. Am J Pathol (1988) 0.98

Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol (1992) 0.98

Neuropathologic findings in surgically treated hemimegalencephaly: immunohistochemical, morphometric, and ultrastructural study. Acta Neuropathol (1992) 0.88

Immunohistochemical colocalization of amyloid precursor protein with cerebrovascular amyloid of Alzheimer's disease. Am J Pathol (1991) 0.82

Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathol (1994) 0.79

Relationship of amyloid to Alzheimer's disease. West J Med (1991) 0.77

Does aluminium have a pathogenic role in dialysis associated arthropathy? Ann Rheum Dis (1990) 0.75

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33

Classification of primary progressive aphasia and its variants. Neurology (2011) 11.82

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29

Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology (2002) 5.03

In vivo nitrate reduction in relation to nitrate uptake, nitrate content, and in vitro nitrate reductase activity in intact barley seedlings. Plant Physiol (1976) 4.16

The logopenic/phonological variant of primary progressive aphasia. Neurology (2008) 3.95

Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology (2007) 3.71

Race/ethnic differences in AD survival in US Alzheimer's Disease Centers. Neurology (2007) 3.18

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology (2007) 2.65

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology (2011) 2.61

Direct and indirect gene replacements in Aspergillus nidulans. Mol Cell Biol (1985) 2.61

Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev (1983) 2.46

Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology (2009) 2.46

Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem (1990) 2.45

Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol (1996) 2.45

Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology (2007) 2.43

Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology (2011) 2.42

Predictors of brain morphology for the men of the NHLBI twin study. Stroke (1999) 2.41

Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology (2004) 2.37

Apathy is not depression. J Neuropsychiatry Clin Neurosci (1998) 2.24

Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol (2001) 2.22

The natural history of temporal variant frontotemporal dementia. Neurology (2005) 2.22

StuA is required for cell pattern formation in Aspergillus. Genes Dev (1992) 2.14

Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology (2005) 2.10

Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology (2007) 2.09

Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology (1998) 2.09

Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2008) 2.00

Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke (1998) 1.99

Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A (1999) 1.93

TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology (2010) 1.93

A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology (2005) 1.93

Visual hallucinations. Clinical occurrence and use in differential diagnosis. West J Med (1987) 1.91

Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A (1996) 1.91

Atrophy rates of entorhinal cortex in AD and normal aging. Neurology (2003) 1.88

Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology (2006) 1.80

Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study. Arthritis Rheum (1989) 1.80

Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology (1999) 1.79

Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology (2006) 1.78

The temporal variant of frontotemporal dementia. Brain (1997) 1.76

Atrophy progression in semantic dementia with asymmetric temporal involvement: a tensor-based morphometry study. Neurobiol Aging (2007) 1.74

Transport of metabolic substrates through the blood-brain barrier. J Neurochem (1977) 1.73

Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology (2011) 1.66

Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology (2004) 1.64

Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. J Pharmacol Exp Ther (2000) 1.63

Thyroid function in nonthyroidal illnesses. Ann Intern Med (1983) 1.62

Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev (2001) 1.62

Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. Arch Neurol (1992) 1.59

First symptom in sporadic Creutzfeldt-Jakob disease. Neurology (2006) 1.58

Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy. Ann Neurol (1990) 1.57

Identification of Gram negative bacteria using nanoscale silicon microcavities. J Am Chem Soc (2001) 1.55

Autonomy & the refusal of lifesaving treatment. Hastings Cent Rep (1981) 1.55

Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J Neuroimmunol (2001) 1.52

Aspergillus SteA (sterile12-like) is a homeodomain-C2/H2-Zn+2 finger transcription factor required for sexual reproduction. Mol Microbiol (2000) 1.51

Human blood-brain barrier transferrin receptor. Metabolism (1987) 1.50

TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia. Neurology (2010) 1.49

Spatial cognition and the human navigation network in AD and MCI. Neurology (2007) 1.48

Human blood-brain barrier insulin receptor. J Neurochem (1985) 1.47

Position-dependent and -independent mechanisms regulate cell-specific expression of the SpoC1 gene cluster of Aspergillus nidulans. Mol Cell Biol (1987) 1.47

Glucose transport and phosphorylation: which is rate limiting for brain glucose utilization? Ann Neurol (1994) 1.46

Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI. Neurology (2010) 1.46

Self awareness and personality change in dementia. J Neurol Neurosurg Psychiatry (2005) 1.45

Hemispheric dominance for emotions, empathy and social behaviour: evidence from right and left handers with frontotemporal dementia. Neurocase (2001) 1.44

Clinical advances in degenerative dementias. Br J Psychiatry (1997) 1.43

Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest (1997) 1.43

Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem (1987) 1.42

Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A (2000) 1.42

Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest (1979) 1.42

Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res (1987) 1.42

StuAp is a sequence-specific transcription factor that regulates developmental complexity in Aspergillus nidulans. EMBO J (1997) 1.42

Structure and regulated expression of the SpoC1 gene cluster from Aspergillus nidulans. J Mol Biol (1984) 1.40

Bioavailable testosterone in salivary glands. Clin Chem (1991) 1.39

Comparison of family histories in FTLD subtypes and related tauopathies. Neurology (2005) 1.39

Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc Natl Acad Sci U S A (1989) 1.39

Isolation and transcriptional characterization of a morphological modifier: the Aspergillus nidulans stunted (stuA) gene. Mol Gen Genet (1991) 1.38

Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest (1997) 1.37

Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci (1993) 1.37

Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology (2002) 1.37

Anatomical correlates of early mutism in progressive nonfluent aphasia. Neurology (2006) 1.36

Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev (1986) 1.35

Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology (2009) 1.34

Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann Neurol (2001) 1.34

Inheritance of frontotemporal dementia. Arch Neurol (1999) 1.34

Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations. Neurology (2007) 1.33

Kinetics of blood-brain barrier transport of pyruvate, lactate and glucose in suckling, weanling and adult rats. J Neurochem (1979) 1.33

Kinetics of blood-brain transport of hexoses. Biochim Biophys Acta (1975) 1.32

Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry (1996) 1.31

Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res (2000) 1.31

Brain atrophy associated with baseline and longitudinal measures of cognition. Neurobiol Aging (2009) 1.31

Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology (2002) 1.29

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology (2000) 1.29

The influence of right frontotemporal dysfunction on social behavior in frontotemporal dementia. Neurology (2001) 1.28

Multicenter validation of a bedside antisaccade task as a measure of executive function. Neurology (2012) 1.26

Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology (2005) 1.26

Focal right inferotemporal atrophy in AD with disproportionate visual constructive impairment. Neurology (2003) 1.25

Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc Natl Acad Sci U S A (1991) 1.24

Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology (2003) 1.22

Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Brain Res Mol Brain Res (1994) 1.20

Factor analysis of four measures of prefrontal lobe functioning. Arch Clin Neuropsychol (1998) 1.20

hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo. Biochem Biophys Res Commun (1999) 1.19